Pradeep Khosla
Showing 1–3 of 3 transcripts.
- Milken Institute1h 1m
Building Tomorrow's Workforce Today
Rick Newman, Pradeep Khosla, Daphne Kis, Chauncy Lennon, Jane Oates
Driven by a paradox of low unemployment and stagnant labor force participation, the U.S. is confronting structural flaws in its outdated training systems and opaque credentialing infrastructure. In response, initiatives like Credential Engine are deploying transparency databases while educational models such as P-TECH and Swiss-style apprenticeships are scaling to align workforce skills with industry demands. Despite these reforms, experts warn that addressing equity gaps and a looming faculty shortage remains critical to transitioning from a degree-centric culture to one focused on long-term adaptability and competency-based matching.
- Milken Institute1h 2m
California and Asia: The Need for Collaboration
Kevin Klowden, Fred Hochberg, Elise Huang, Pradeep Khosla, Ashok Kumar Mirpuri
A panel of experts warns that shifting U.S. trade policies and proposed federal budget cuts threaten California's role as the primary gateway for Pacific economic and technological engagement. While China and Singapore aggressively expand their influence through strategic investments, regulatory sandboxes, and bilateral partnerships, the United States faces significant risks to its leadership in R&D, education, and export markets. The discussion highlights that sustaining California's innovation ecosystem requires immediate government support to counteract global shifts in semiconductor manufacturing and fintech dominance.
- Milken Institute1h 4m
Precision Medicine: Accelerating Treatments From Potential to Reality
Mike Milken, Margaret Anderson, Pradeep Khosla, Brian Drucker, Betsy Nabel, Sam Hoggud
Distinguished experts including Pradeep Khosla, Brian Drucker, and Sam Hogg convened to discuss the transformation of medicine into a collaborative, data-driven field where precision and artificial intelligence have replaced traditional research silos. Despite significant breakthroughs like the rapid development of Gleevec, panelists warned that underfunding, a lack of trained physician-scientists, and intense global competition threaten U.S. leadership in the bioscience sector. The group concluded that realizing this "golden age of medicine" requires an urgent Apollo-style initiative, multi-sector co-investment, and a cultural shift toward patient partnerships to secure global health preeminence.